Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05857488 · ClinicalTrials.gov registry record · NA
Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at UVa
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05857488: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT05857488 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05857488, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.
Primary Outcome
Can the technology successfully collect images of the small intestine in an unseated infant?
Interventions
- DEVICE Transnasal introduction tube
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2022-06-17 |
| Phase | NA |
Why NCT05857488 stopped before completion
NCT05857488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Transnasal introduction tube is the first listed.
NCT05857488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05857488 about?
NCT05857488 is a clinical study titled "Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at UVa". The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.
What is the current status of trial NCT05857488?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-01-01. Estimated completion is 2022-06-17.
What interventions are being tested in trial NCT05857488?
The interventions under investigation include: Transnasal introduction tube (DEVICE).
Who is sponsoring clinical trial NCT05857488?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05857488's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI